Comparison of Pretic-I Versus Discover Disc Arthroplasty As Treatment for Single-level Cervical Disc Degenerative Disease With 5-year Follow-up

Yingjun Guo,Hao Liu,Jianzhong Xu,Yuxiao Deng,Xiaoliang Tao,Yang Meng,Xiaofei Wang,Ying Hong,Beiyu Wang,Chen Ding,Wenjie Wu
DOI: https://doi.org/10.21203/rs.3.rs-731985/v1
2021-01-01
Abstract:Abstract Background: The newly designed cervical disc prosthesis, Pretic-I, had been finished its limited clinical use for over 5 years. At a short-term follow-up of 2 years, we obtained satisfactory clinical results. The long-term clinical efficacy and safety of Pretic-I will now be analyzed. Methods: Peri-operative parameters included intra-operative blood loss, operation time, off-bed time. Clinical parameters included visual analogue scale (VAS) for arm and neck, neck disability index (NDI), and Japanese Orthopaedic Association (JOA) score. Radiological parameters included C2-7 Cobb angle, Shell angle, and the range of motion (ROM) of C2-7, functional segment unit (FSU), and adjacent FSU. The CDA-related complications included adjacent segment degeneration (ASDeg), adjacent segment disease (ASDis) , heterotopic ossification (HO), prosthesis subsidence, prosthesis displacement, and dysphagia.Results: A total 64 patients from two independent centers received a single-level CDA with Discover (n=32) and Pretic-I (n=32), and all of patients finished a 5-year follow-up. There’re no significant differences between two groups in peri-operative parameters. The clinical parameters improved greatly in Pretic-I group (p<0.0001), and there’s no statistical difference from Discover group. Furthermore, Pretic-I could slightly improve the cervical curvature (15.08±11.75 to 18.00±10.61, p=0.3079) and perfectly maintain the Shell angle (3.03±3.68 to 2.23±4.10, p=0.1988), cervical ROM (52.48±14.31 to 53.30±11.71, p=0.8062) and FSU ROM (12.20±4.52 to 10.73±4.45, p=0.2002). The incidence of high-grade HO (Grade III-IV) at the final follow-up was significantly lower in Pretic-I group than in Discover group (12.50% vs. 34.38%, p=0.0389, Statistical Power=95.36%). The incidences of other CDA-related complications in Pretic-I group were also well-accepted, comparable to the Discover group, without significant differences.Conclusion: CDA with Pretic-I demonstrated a well-accepted and sustained clinical outcome, with a significantly lower incidence of high-grade HO. This newly designed prosthesis is expected to become an alternative choice for cervical disc prosthesis in the future.
What problem does this paper attempt to address?